AVESTHAGEN’s first biosimilar molecule AVDESP™ completes Clinical Batch Manufacturing in Malaysia, to move to Clinical Trials
AVESTHAGEN’s first biosimilar molecule AVDESP™ completes Clinical Batch Manufacturing in Malaysia, to move to Clinical Trials.. View More
Byadmin
By
Vegan-friendly Muesli from ‘Good Earth’, All India
Vegan-friendly Muesli from ‘Good Earth’, All India.. View More
Byadmin
Biosimilar drug effective in addressing arthritic conditions to make significant entry into the $6.5 billion Enbrel market
Biosimilar drug effective in addressing arthritic conditions to make significant entry into the $6.5 billion Enbrel market.. View…
Byadmin
‘Our focus is on consolidating at the moment,’ says Villoo Patell of Avesthagen
Bangalore-based life sciences company Avesthagen Ltd is restructuring its business by splitting it into four separate firms.. View…
Byadmin
World Economic Forum honours Avesthagen India as a Global Growth Company
Avesthagen was selected as one of the seventeen of the region’s most dynamic and high-growth companies considered to…
Byadmin